Yale Accelerator Funds
Advancing Yale discoveries through strategic funding and expert support
Yale Ventures accelerator funds are designed to propel groundbreaking Yale research into real-world impact.
These funds support faculty-led ventures that span the biotechnology, immunity, healthtech, engineering, and planetary solutions—transforming bold ideas into scalable solutions for some of the world’s most urgent challenges.
What We Offer
Yale accelerator funds provide more than just capital. Each selected team gains access to:
Targeted funding to advance research toward commercialization.
Mentorship from EIRs and IIRs: industry leaders and Yale’s network of executives and investors.
Mentorship from our experienced team of business and venture development teams, fellows and student associates.
Innovation and entrepreneurship training tailored to your domain from workshops to asynchronous resources.
Hands-on support navigating the startup journey.
Strategic exposure to investors and early partners.
Built Around Faculty, Focused on Impact
Whether you’re developing a biotech therapy, a climate-resilient material, a public health solution, a new form of creative expression, or the next engineering breakthrough, Yale Ventures is here to help translate your research into a venture ready to change the world. Our accelerator funds are designed not just to launch companies—but to deliver outcomes: improving human health, saving lives, advancing equity, protecting the planet, and enriching society. To date, our most established fund, the Blavatnik Fund for Innovation at Yale, has supported 98 projects with over $24 million in funding—fueling the formation of 35 biotech companies and the launch of 8 clinical trials.
150
Faculty Ventures Launched
$5.75M
Translational Funding Awarded
FY '25
$286M+
Venture funding raised
FY '25
One Mission, Many Pathways
Our accelerator funds each focus on specific innovation domains—but they’re united by a shared mission: to support the commercialization of transformative Yale discoveries. Cross-fund collaboration, shared infrastructure, and a common mentorship network ensure each team benefits from the full strength of the Yale Ventures ecosystem.
AUTOIMMUNITY